期刊文献+

五劳七损方对强直性脊柱炎患者Dickkopf-1蛋白水平的影响 被引量:5

Effect of Wulao Qisun Formula on the Level of Dickkopf-1 of Ankylosing Spondylitis
原文传递
导出
摘要 目的:探索五劳七损方治疗强直性脊柱炎(AS)的有效性、安全性及可能的作用机理。方法:本研究应用ELISA的实验方法检测45例AS患者(AS组)治疗前后及50名健康人(健康组)血清Dickkopf-1(DKK-1)蛋白水平,并检测AS组治疗前后血沉(ESR)、C反应蛋白(CRP)含量及相关临床疗效评价指标。治疗过程中观察不良反应。结果:治疗前AS组血清DKK-1水平明显低于健康组(P<0.05),经五劳七损方治疗后血清DKK-1水平较治疗前明显升高(P<0.05),且与对照组比较差异无统计学意义(P<0.05)。治疗后ESR和CRP较治疗前均明显降低(P<0.05或P<0.01);相关临床疗效评价指标均较治疗前均明显改善(P<0.05)。患者治疗过程中未见明显不良反应。结论:五劳七损方改善AS患者临床症状、体征疗效显著,其作用机制可能是通过升高血清DKK-1水平实现的。 Objective:To observe the effect of Wulao Qisun formula on the level of Dickkopf-1(DKK1)in patients with ankylosing spondylitis(AS).Methods:The level of DKK1 was detected before and after treatment in 45 cases of AS(AS group)and 50 healthy people(control group)by enzyme-linked immunosorbent assay method.The levels of erythrocyte sedimentation rate(ESR),C-reactive protein(CRP),and evaluation index of clinical efficacy were detected in AS group.The adverse reactions were observed in the treatment.Results:Before treatment,the level of DKK-1in the AS group was significantly lower than that of healthy group(P〈0.05).After treatment,the level of DKK-1was significantly increased in the AS group(P〈0.05)and there was no significant difference between two groups(P〈0.05).The levels of ESR and CRP,and the evaluation index of clinical efficacy were significantly improved after treatment(P〈0.05).There was no obvious adverse reaction occurring during the treatment.Conclusion:Wulao Qisun formula is effective and safe for treating AS,and its mechanism may be achieved by increasing the level of serum DKK-1.
机构地区 甘肃省中医院
出处 《中国中医骨伤科杂志》 CAS 2016年第3期26-28,共3页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
基金 甘肃省兰州市科技惠民计划项目(1209FCMA029)
关键词 强直性脊柱炎 五劳七损方 Dickkopf-1蛋白 ankylosing spondylitis Wulao Qisun formula dickkopf-1
  • 相关文献

参考文献15

  • 1Machado P, Landewe R, Braun J, et al. Both structural damage and inflammation of the spine contribute to im- pairment of spinal mobility in patients with ankylosing spondylitis[J]. Ann Rheum Dis,2010,69(8) .1465-1470.
  • 2Heiland GR, Appel H, Poddubnyy D, et al. High level of functional dickkopf-1 predicts protection from syndesmo- phyte formation in patients with ankylosing spondylitis [J]. Ann Rheum Dis,2012,71(4):572-574.
  • 3Uderhardt S, Diarra D, Katzenbeisser J, et al. Blockade of Dickkopf (DKK)-I induces fusion of sacroiliac joints[J]. Ann Rheum Dis,2010,69(3):592-597.
  • 4Schett G,Zwerina J ,David JP. The role of Wnt proteins in arthritis[J]. Nat Clin Pract Rheumatol, 2008,4 ( 9 ) : 473- 480.
  • 5Luyten FP, Tylzanowski P, Lories RJ. Wnt signaling and osteoarthritis[J]. Bone,2009,44(4) :522-527.
  • 6苏小军,王海东,田雪梅,王爱华,吴燕,李伟青.五劳七损方治疗强直性脊柱炎50例临床研究[J].新中医,2013,45(11):52-54. 被引量:7
  • 7国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:208.
  • 8Van der Linden S,Valkenburg HA,Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis a proposal for modification of the Nev York criteria[J]. Arithritis Rheum, 2009,27 :a61-368.
  • 9Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis[J]. Nat Clin Pract Rheumatol, 2008,4 (9) 473- 480. d.
  • 10e Grandmont P, Feine JS,Tache R, et al. Within-subject comparisons of implant-supported mandibular prostheses: psychometric evaluation [J]. J Dent Res, 1994, 73 ( 5 ) : 1096-1104.

二级参考文献26

  • 1张延昌,杨扶德,田雪梅,张宏武.《武威汉代医简》方药注解[J].甘肃中医,2005,18(1):14-16. 被引量:6
  • 2中药新药临床研究指导原则(试行)[M].北京中国医药科技出版社,2002.
  • 3JONES S D,STEINER A,GARRETT S L,et al.The bathankylosing spondylitis patient global score (BAS-G)[J].British Journal of Rheumatology,1996,35:66-71.
  • 4GARRETT S,JENKINSON T,KENNEDY L G,et al.A newapproach to defining disease status in ankylosing spondylitis:The bath ankylosing spondylitis disease activity index[J].The Journal of Rheumatology,1994,21 (12):2286-2291.
  • 5CALIN A,GARRETT S,WHITELOCK H,et al.A new approach to defining functional ability in ankylosing sponkylitis:The development of the bath ankylosng sponkylitis functional index[J].The Journal of Rheumatology,1994,21 (12):2281-2285.
  • 6HUANG F,GU J,ZHAO W,et al.One-year open-label trial of thalidomide in ankylosing spondyliti[J].Arthritis&Rheumatism,2002,47 (3):249-254.
  • 7陈灏珠,林为果实用内科学[M].北京:人民卫生出版社,2009:2723-2725.
  • 8Jones SD, Steiner A, Garrett SL, et al. The bathankylosing spondylitis patient global score(BAS- G)[J]. British Journal of Rheumatology, 1996, 35(1): 66-71.
  • 9胡萌奇,韩永刚名老中医治风湿病经验[M]北京:军事医学科学出版社,2006:142-153.
  • 10Braun J,Bollow M,Remlinger G,et al.Prevalence of spondylarthropathies in HLA-B27 positive and negative blooddonors[J].Arthritis Rheum,1998,41(1):58-67.

共引文献189

同被引文献36

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部